Perceptions about the implementation of physiotherapist prescribing in Australia: a national survey of Australian physiotherapists

Timothy David Noblet, John F. Marriott, Taryn Jones, Catherine Dean, Alison B. Rushton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objectives: To explore: (1) the views of Australian physiotherapists regarding potential implementation of non-medical prescribing in Australia, (2) how the geographical location and health sector in which a clinician works may influence their perceptions and (3) the perceptions of Australian physiotherapists about how physiotherapist prescribing might impact the care that the profession can provide. Design: A cross-sectional descriptive survey using open and closed questions. Setting: Participants completed an online questionnaire. Participants: 883 Australian Health Professionals Registration Authority (AHPRA)-registered physiotherapists, working across all states and territories. Outcome measures An online questionnaire was developed by a panel of subject experts and pretested (n=10) for internal consistency. A hyperlink to the questionnaire was emailed to all members of the Australian Physiotherapy Association. A reminder email was sent 4 weeks later. Quantitative data were analysed descriptively, with use of absolute risk reductions (ARRs) and 95% CIs to determine the likelihood that health sector or geographical location were associated with specific views. Thematic analysis enabled synthesis of the qualitative data. Results: 79.0% participants felt that physiotherapist prescribing should be introduced in Australia, with 71.2% wanting to train as prescribers. Clinical governance, risk management, regulation of clinicians and the development of an education framework were identified as priorities for implementation. Participants working in the private sector were significantly more likely to train as prescribers than those in the public sector (ARR 9.9%; 95% CI 3.5 to 16.4) or educational/research institutions (ARR 23.3%; 95% CI 12.8 to 33.8), with city dwellers significantly more likely to train compared with physiotherapists in remote regions (ARR 19.8%; 95% CI 0.8 to 39.2). Physiotherapist prescribing was predicted to improve efficiency of healthcare delivery, access to medicines and reductions in healthcare costs. Conclusions: AHPRA-registered physiotherapists perceive that the introduction of autonomous physiotherapist prescribing would be beneficial for the Australian population and should be introduced. Decision makers should consider the results of this survey in conjunction with cost-benefit and risk analysis when planning the introduction of physiotherapist prescribing.

LanguageEnglish
Article number024991
Pages1-14
Number of pages14
JournalBMJ Open
Volume9
Issue number5
DOIs
Publication statusPublished - 17 May 2019

Fingerprint

Physical Therapists
Numbers Needed To Treat
Health
Surveys and Questionnaires
Clinical Governance
Private Sector
Public Sector
Risk Management
Health Care Costs
Cost-Benefit Analysis
Cross-Sectional Studies
Outcome Assessment (Health Care)
Delivery of Health Care
Education

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Australia
  • non-medical prescribing
  • perceptions
  • physiotherapy
  • questionnaire
  • survey
  • views

Cite this

@article{96941c21db69418da1fba7f860f45a37,
title = "Perceptions about the implementation of physiotherapist prescribing in Australia: a national survey of Australian physiotherapists",
abstract = "Objectives: To explore: (1) the views of Australian physiotherapists regarding potential implementation of non-medical prescribing in Australia, (2) how the geographical location and health sector in which a clinician works may influence their perceptions and (3) the perceptions of Australian physiotherapists about how physiotherapist prescribing might impact the care that the profession can provide. Design: A cross-sectional descriptive survey using open and closed questions. Setting: Participants completed an online questionnaire. Participants: 883 Australian Health Professionals Registration Authority (AHPRA)-registered physiotherapists, working across all states and territories. Outcome measures An online questionnaire was developed by a panel of subject experts and pretested (n=10) for internal consistency. A hyperlink to the questionnaire was emailed to all members of the Australian Physiotherapy Association. A reminder email was sent 4 weeks later. Quantitative data were analysed descriptively, with use of absolute risk reductions (ARRs) and 95{\%} CIs to determine the likelihood that health sector or geographical location were associated with specific views. Thematic analysis enabled synthesis of the qualitative data. Results: 79.0{\%} participants felt that physiotherapist prescribing should be introduced in Australia, with 71.2{\%} wanting to train as prescribers. Clinical governance, risk management, regulation of clinicians and the development of an education framework were identified as priorities for implementation. Participants working in the private sector were significantly more likely to train as prescribers than those in the public sector (ARR 9.9{\%}; 95{\%} CI 3.5 to 16.4) or educational/research institutions (ARR 23.3{\%}; 95{\%} CI 12.8 to 33.8), with city dwellers significantly more likely to train compared with physiotherapists in remote regions (ARR 19.8{\%}; 95{\%} CI 0.8 to 39.2). Physiotherapist prescribing was predicted to improve efficiency of healthcare delivery, access to medicines and reductions in healthcare costs. Conclusions: AHPRA-registered physiotherapists perceive that the introduction of autonomous physiotherapist prescribing would be beneficial for the Australian population and should be introduced. Decision makers should consider the results of this survey in conjunction with cost-benefit and risk analysis when planning the introduction of physiotherapist prescribing.",
keywords = "Australia, non-medical prescribing, perceptions, physiotherapy, questionnaire, survey, views",
author = "Noblet, {Timothy David} and Marriott, {John F.} and Taryn Jones and Catherine Dean and Rushton, {Alison B.}",
note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "5",
day = "17",
doi = "10.1136/bmjopen-2018-024991",
language = "English",
volume = "9",
pages = "1--14",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "British Medical Journal Publishing Group",
number = "5",

}

Perceptions about the implementation of physiotherapist prescribing in Australia : a national survey of Australian physiotherapists. / Noblet, Timothy David; Marriott, John F.; Jones, Taryn; Dean, Catherine; Rushton, Alison B.

In: BMJ Open, Vol. 9, No. 5, 024991, 17.05.2019, p. 1-14.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Perceptions about the implementation of physiotherapist prescribing in Australia

T2 - BMJ Open

AU - Noblet, Timothy David

AU - Marriott, John F.

AU - Jones, Taryn

AU - Dean, Catherine

AU - Rushton, Alison B.

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/5/17

Y1 - 2019/5/17

N2 - Objectives: To explore: (1) the views of Australian physiotherapists regarding potential implementation of non-medical prescribing in Australia, (2) how the geographical location and health sector in which a clinician works may influence their perceptions and (3) the perceptions of Australian physiotherapists about how physiotherapist prescribing might impact the care that the profession can provide. Design: A cross-sectional descriptive survey using open and closed questions. Setting: Participants completed an online questionnaire. Participants: 883 Australian Health Professionals Registration Authority (AHPRA)-registered physiotherapists, working across all states and territories. Outcome measures An online questionnaire was developed by a panel of subject experts and pretested (n=10) for internal consistency. A hyperlink to the questionnaire was emailed to all members of the Australian Physiotherapy Association. A reminder email was sent 4 weeks later. Quantitative data were analysed descriptively, with use of absolute risk reductions (ARRs) and 95% CIs to determine the likelihood that health sector or geographical location were associated with specific views. Thematic analysis enabled synthesis of the qualitative data. Results: 79.0% participants felt that physiotherapist prescribing should be introduced in Australia, with 71.2% wanting to train as prescribers. Clinical governance, risk management, regulation of clinicians and the development of an education framework were identified as priorities for implementation. Participants working in the private sector were significantly more likely to train as prescribers than those in the public sector (ARR 9.9%; 95% CI 3.5 to 16.4) or educational/research institutions (ARR 23.3%; 95% CI 12.8 to 33.8), with city dwellers significantly more likely to train compared with physiotherapists in remote regions (ARR 19.8%; 95% CI 0.8 to 39.2). Physiotherapist prescribing was predicted to improve efficiency of healthcare delivery, access to medicines and reductions in healthcare costs. Conclusions: AHPRA-registered physiotherapists perceive that the introduction of autonomous physiotherapist prescribing would be beneficial for the Australian population and should be introduced. Decision makers should consider the results of this survey in conjunction with cost-benefit and risk analysis when planning the introduction of physiotherapist prescribing.

AB - Objectives: To explore: (1) the views of Australian physiotherapists regarding potential implementation of non-medical prescribing in Australia, (2) how the geographical location and health sector in which a clinician works may influence their perceptions and (3) the perceptions of Australian physiotherapists about how physiotherapist prescribing might impact the care that the profession can provide. Design: A cross-sectional descriptive survey using open and closed questions. Setting: Participants completed an online questionnaire. Participants: 883 Australian Health Professionals Registration Authority (AHPRA)-registered physiotherapists, working across all states and territories. Outcome measures An online questionnaire was developed by a panel of subject experts and pretested (n=10) for internal consistency. A hyperlink to the questionnaire was emailed to all members of the Australian Physiotherapy Association. A reminder email was sent 4 weeks later. Quantitative data were analysed descriptively, with use of absolute risk reductions (ARRs) and 95% CIs to determine the likelihood that health sector or geographical location were associated with specific views. Thematic analysis enabled synthesis of the qualitative data. Results: 79.0% participants felt that physiotherapist prescribing should be introduced in Australia, with 71.2% wanting to train as prescribers. Clinical governance, risk management, regulation of clinicians and the development of an education framework were identified as priorities for implementation. Participants working in the private sector were significantly more likely to train as prescribers than those in the public sector (ARR 9.9%; 95% CI 3.5 to 16.4) or educational/research institutions (ARR 23.3%; 95% CI 12.8 to 33.8), with city dwellers significantly more likely to train compared with physiotherapists in remote regions (ARR 19.8%; 95% CI 0.8 to 39.2). Physiotherapist prescribing was predicted to improve efficiency of healthcare delivery, access to medicines and reductions in healthcare costs. Conclusions: AHPRA-registered physiotherapists perceive that the introduction of autonomous physiotherapist prescribing would be beneficial for the Australian population and should be introduced. Decision makers should consider the results of this survey in conjunction with cost-benefit and risk analysis when planning the introduction of physiotherapist prescribing.

KW - Australia

KW - non-medical prescribing

KW - perceptions

KW - physiotherapy

KW - questionnaire

KW - survey

KW - views

UR - http://www.scopus.com/inward/record.url?scp=85065994656&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-024991

DO - 10.1136/bmjopen-2018-024991

M3 - Article

VL - 9

SP - 1

EP - 14

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 5

M1 - 024991

ER -